Classic congenital adrenal hyperplasia and its impact on reproduction

Imagem de Miniatura
Arquivos
art_GOMES_Classic_congenital_adrenal_hyperplasia_and_its_impact_on_2019.PDF (196.82 KB)
Citações na Scopus
39
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
Autor de Grupo de pesquisa
Citação
FERTILITY AND STERILITY, v.111, n.1, p.7-12, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Women with classic congenital adrenal hyperplasia (CAH) can suffer from impaired fertility rates as a result of increased androgen secretion or impaired sex steroid production. In virilizing CAH forms, such as 21-hydroxylase and 11 beta-hydroxylase deficiency, the low reported pregnancy rate is mainly secondary to a diminished desire to conceive. Optimal glucocorticoid and/or mineralocorticoid replacement, sufficient to normalize androgen and P levels in the follicular phase, allows natural conception in most cases. The remaining CAH forms exemplified by StAR, P450scc, P450-oxidoreductase, and 17 alpha-hydroxylase/17-20 lyase deficiencies are associated with impaired sex steroid production. Several factors are involved in the true low fertility rate in this group: folliculogenesis arrest, uterine hypoplasia, and inadequate endometrial thickness related to aberrant androgen, estrogen, and P secretion. There are several reports of successful term pregnancies achieved through controlled ovarian hyperstimulation, followed by estrogen replacement and IVF. Progress in female genitalia reconstructive surgery, individualized hormonal therapies, psychosexual evaluation, and assisted reproductive technology have improved fertility and pregnancy outcomes in women with classic CAH. Finally, successful gestational management in CAH patients requires the close coordination of care between endocrinologists and obstetricians. (C) 2018 by American Society for Reproductive Medicine.
Palavras-chave
Congenital adrenal hyperplasia, fertility, reproduction
URI
https://observatorio.fm.usp.br/handle/OPI/30783
Referências
  1. Alos N, 2000, J CLIN ENDOCR METAB, V85, P1968, DOI 10.1210/jc.85.5.1968
  2. Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004
  3. Auchus RJ, 2001, ENDOCRIN METAB CLIN, V30, P101, DOI 10.1016/S0889-8529(08)70021-5
  4. Bachelot A, 2012, EUR J ENDOCRINOL, V167, P499, DOI 10.1530/EJE-12-0454
  5. Bonamichi BDSF, 2016, ARCH ENDOCRIN METAB, V60, P500, DOI 10.1590/2359-3997000000213
  6. Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503
  7. Casteras A, 2009, CLIN ENDOCRINOL, V70, P833, DOI 10.1111/j.1365-2265.2009.03563.x
  8. Chien Y, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110833
  9. Costa EMF, 1997, FERTIL STERIL, V67, P229
  10. de Carvalho LC, 2016, FERTIL STERIL, V105, P1612, DOI 10.1016/j.fertnstert.2016.02.008
  11. Bianchi PHD, 2016, J CLIN ENDOCR METAB, V101, P345, DOI 10.1210/jc.2015-3201
  12. Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300
  13. Fluck CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020178
  14. Fluck CE, 2011, ENDOCR DEV, V20, P63, DOI 10.1159/000321221
  15. Fujieda K, 1997, J CLIN INVEST, V99, P1265, DOI 10.1172/JCI119284
  16. Fukami M, 2009, J CLIN ENDOCR METAB, V94, P1723, DOI 10.1210/jc.2008-2816
  17. Guaragna G, 2012, ARQ BRAS ENDOCRINOL, V56, P578, DOI 10.1590/S0004-27302012000800020
  18. HAGUE WM, 1990, CLIN ENDOCRINOL, V33, P501, DOI 10.1111/j.1365-2265.1990.tb03887.x
  19. Hauffa B, 2011, ENDOCR DEV, V20, P54, DOI 10.1159/000321215
  20. Hershkovitz E, 2008, J CLIN ENDOCR METAB, V93, P3584, DOI 10.1210/jc.2008-0051
  21. Hoepffner W, 2004, FERTIL STERIL, V81, P1314, DOI 10.1016/j.fertnstert.2003.10.024
  22. HOLMESWALKER DJ, 1995, CLIN ENDOCRINOL, V43, P291
  23. Idkowiak J, 2011, J CLIN ENDOCR METAB, V96, pE453, DOI 10.1210/jc.2010-1607
  24. Jaaskelainen J, 2000, ACTA OBSTET GYN SCAN, V79, P687, DOI 10.1034/j.1600-0412.2000.079008687.x
  25. Khattab A, 2017, P NATL ACAD SCI USA, V114, pE1933, DOI [10.1073/pnas.1621082114, 10.1073/pnas.1621082114/-/DCSupplemental]
  26. Khoury K, 2009, J CLIN ENDOCR METAB, V94, P1333, DOI 10.1210/jc.2008-1694
  27. Kim Chan Jong, 2014, Ann Pediatr Endocrinol Metab, V19, P179, DOI 10.6065/apem.2014.19.4.179
  28. Levran D, 2003, J ASSIST REPROD GEN, V20, P21, DOI 10.1023/A:1021206704958
  29. Lim JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09880-0
  30. Lo JC, 2001, ENDOCRIN METAB CLIN, V30, P207, DOI 10.1016/S0889-8529(08)70027-6
  31. Marsh CA, 2014, FERTIL STERIL, V101, P317, DOI 10.1016/j.fertnstert.2013.11.011
  32. Martin RM, 2003, J CLIN ENDOCR METAB, V88, P5739, DOI 10.1210/jc.2003-030988
  33. Mermejo LM, 2005, J CLIN ENDOCR METAB, V90, P1287, DOI 10.1210/jc.2004-1552
  34. Meyer-Bahlburg HFL, 2008, ARCH SEX BEHAV, V37, P85, DOI 10.1007/s10508-007-9265-1
  35. Meyer-Bahlburg HFL, 2006, ARCH SEX BEHAV, V35, P667, DOI 10.1007/s10508-006-9068-9
  36. Miller WL, 1998, CLIN PERINATOL, V25, P799
  37. Miller WL, 2005, ENDOCRINOLOGY, V146, P2544, DOI 10.1210/en.2005-0096
  38. Miura K, 1996, J CLIN ENDOCR METAB, V81, P3797, DOI 10.1210/jc.81.10.3797
  39. Moore AM, 2016, J STEROID BIOCHEM, V160, P106, DOI 10.1016/j.jsbmb.2015.10.002
  40. MULAIKAL RM, 1987, NEW ENGL J MED, V316, P178, DOI 10.1056/NEJM198701223160402
  41. Nordenstrom A, 2010, J CLIN ENDOCR METAB, V95, P3633, DOI 10.1210/jc.2009-2639
  42. Ogilvie CM, 2006, EUR J ENDOCRINOL, V154, P405, DOI 10.1530/eje.1.02096
  43. Peter M, 2002, SEMIN REPROD MED, V20, P249, DOI 10.1055/s-2002-35389
  44. Pielecka J, 2006, ENDOCRINOLOGY, V147, P1474, DOI 10.1210/en.2005-1029
  45. Reichman DE, 2014, FERTIL STERIL, V101, P301, DOI 10.1016/j.fertnstert.2013.11.002
  46. Sertedaki A, 2009, FERTIL STERIL, V91, DOI 10.1016/j.fertnstert.2008.07.1770
  47. Simard J, 1996, J ENDOCRINOL, V150, pS189
  48. Simitsidellis I, 2018, MOL CELL ENDOCRINOL, V465, P48, DOI 10.1016/j.mce.2017.09.022
  49. Simm PJ, 2007, HORM RES, V68, P294, DOI 10.1159/000107651
  50. Sircili Maria Helena Palma, 2006, Clinics, V61, P209, DOI 10.1590/S1807-59322006000300005
  51. Solorzano CMB, 2010, BJOG-INT J OBSTET GY, V117, P143, DOI 10.1111/j.1471-0528.2009.02383.x
  52. Song TR, 2018, GYNECOL ENDOCRINOL, V34, P385, DOI 10.1080/09513590.2017.1393663
  53. Sowikowska-Hilczer J, 2017, FERTIL STERIL, V108, P822, DOI 10.1016/j.fertnstert.2017.08.013
  54. Speiser PW, 2018, J CLIN ENDOCR METAB, V103, P4043, DOI 10.1210/jc.2018-01865
  55. Speiser PW, 2010, J CLIN ENDOCR METAB, V95, P4133, DOI 10.1210/jc.2009-2631
  56. Walters KA, 2018, MOL CELL ENDOCRINOL, V465, P36, DOI 10.1016/j.mce.2017.06.026
  57. White PC, 2012, SEMIN REPROD MED, V30, P400, DOI 10.1055/s-0032-1324724
  58. Wisniewski AB, 2004, J UROLOGY, V171, P2497, DOI 10.1097/01.ju.0000125269.91938.f7
  59. ZACHMANN M, 1970, J CLIN ENDOCR METAB, V30, P719, DOI 10.1210/jcem-30-6-719
  60. ZACHMANN M, 1979, HORM RES, V11, P292, DOI 10.1159/000179067

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/42